Physician Payments Sunshine Rule From CMS Expected By Year's End
Executive Summary
Pharmaceutical companies will have a little more than a year to put together data to comply with CMS regulations for reporting payments made to physicians if the agency meets its current timeline for issuing the rules.
You may also be interested in...
Sunshine Proposal Allows Lump Sum Reporting Of Research Payments To Institutions
CMS-proposed rule would allow companies to report a single figure for research payments to institutions and attribute it to the principal investigator(s), although the agency will not include it when computing physicians’ total receipts from industry. The agency wants more details on what payments are for, calling on firms to break them down by category when more than one expense type is included in a single payment.
HHS’ Holiday Gift To Industry: Delayed Collection Of Physician Payments Data
CMS postpones the deadline for drug makers to begin full implementation of the Sunshine Act until after it issues a final rule on how to collect the data. Current plans are to keep the March 31, 2013, deadline for companies to submit to HHS the data they do collect for 2012.
Sunshine Act Hits Daylight Savings Time; PhRMA Seeks Extension For Physician Payment Reporting
CMS is late on its rules implementing the “Sunshine Act,” and industry hopes that means they have more time before they have to comply with the law. Without the rules, they may be operating in the dark.